OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome
Ludovico Abenavoli, Giuseppe Guido Maria Scarlata, Emidio Scarpellini, et al.
Medicina (2023) Vol. 59, Iss. 3, pp. 594-594
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

The Metabolic Syndrome, a Human Disease
M. Alemany
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2251-2251
Open Access | Times Cited: 23

Non-alcoholic fatty liver disease and gut microbial dysbiosis- underlying mechanisms and gut microbiota mediated treatment strategies
Muthukumaran Jayachandran, Shen Qu
Reviews in Endocrine and Metabolic Disorders (2023) Vol. 24, Iss. 6, pp. 1189-1204
Closed Access | Times Cited: 24

Dysmetabolic comorbidities and non-alcoholic fatty liver disease: a stairway to metabolic dysfunction-associated steatotic liver disease
Carmen Colaci, Maria Luisa Gambardella, Giuseppe Guido Maria Scarlata, et al.
Hepatoma Research (2024) Vol. 10, pp. 16-16
Open Access | Times Cited: 10

The impact of piperine on the metabolic conditions of patients with NAFLD and early cirrhosis: a randomized double-blind controlled trial
Masoud Nouri‐Vaskeh, Payam Hashemi, Naser Hataminia, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7

The Many Faces of Metabolic Dysfunction-Associated Fatty Liver Disease Treatment: From the Mediterranean Diet to Fecal Microbiota Transplantation
Ludovico Abenavoli, Maria Luisa Gambardella, Giuseppe Guido Maria Scarlata, et al.
(2024)
Open Access | Times Cited: 7

Ultrasound Prevalence and Clinical Features of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Diseases: A Real-Life Cross-Sectional Study
Ludovico Abenavoli, Rocco Spagnuolo, Giuseppe Guido Maria Scarlata, et al.
Medicina (2023) Vol. 59, Iss. 11, pp. 1935-1935
Open Access | Times Cited: 16

The Many Faces of Metabolic Dysfunction-Associated Fatty Liver Disease Treatment: From the Mediterranean Diet to Fecal Microbiota Transplantation
Ludovico Abenavoli, Maria Luisa Gambardella, Giuseppe Guido Maria Scarlata, et al.
Medicina (2024) Vol. 60, Iss. 4, pp. 563-563
Open Access | Times Cited: 5

B. longum CKD1 enhances the efficacy of anti-diabetic medicines through upregulation of IL- 22 response in type 2 diabetic mice
Won Jun Kim, Bum Ju Kil, Chaewon Lee, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 4

Role of gut microbiota and immune cells in metabolic-associated fatty liver disease: clinical impact
Anna Alisi, Geoffrey W. McCaughan, Henning Grønbæk
Hepatology International (2024) Vol. 18, Iss. S2, pp. 861-872
Closed Access | Times Cited: 4

Gut Microbiota and Liver Transplantation: Immune Mechanisms behind the Rejection
Ludovico Abenavoli, Giuseppe Guido Maria Scarlata, Maria Rosaria Paravati, et al.
Biomedicines (2023) Vol. 11, Iss. 7, pp. 1792-1792
Open Access | Times Cited: 13

Impact of diet and gut microbiota changes in the development of hepatocellular carcinoma
Giuseppe Guido Maria Scarlata, Claudia Cicino, Rocco Spagnuolo, et al.
Hepatoma Research (2024)
Open Access | Times Cited: 3

The multiple mechanisms and therapeutic significance of rutin in metabolic dysfunction-associated fatty liver disease (MAFLD)
Qianzhuo Wang, Yingjuan Zhang, Ruiling Lu, et al.
Fitoterapia (2024) Vol. 178, pp. 106178-106178
Closed Access | Times Cited: 3

The Role of Gut Microbiota in the Clinical Outcome of Septic Patients: State of the Art and Future Perspectives
Nadia Marascio, Giuseppe Guido Maria Scarlata, Francesco Romeo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9307-9307
Open Access | Times Cited: 8

Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and MACCEs in Patients with Diabetic Foot Ulcers: An Ambispective Longitudinal Cohort Study
Xiuxian Huang, Zhengming Li, Zhenwei Zhai, et al.
Diabetes Metabolic Syndrome and Obesity (2024) Vol. Volume 17, pp. 1119-1130
Open Access | Times Cited: 2

Association between liver enzymes and metabolic syndrome: a study in Bangladeshi adults
Nurshad Ali, Mitu Samadder, Firoz Mahmud, et al.
Expert Review of Endocrinology & Metabolism (2023) Vol. 18, Iss. 6, pp. 541-547
Closed Access | Times Cited: 6

Potential impact of trained innate immunity on the pathophysiology of metabolic dysfunction-associated fatty liver disease
Јannis Kountouras, Evangelos Kazakos, Stergios A. Pοlyzos, et al.
Clinical Immunology (2023) Vol. 256, pp. 109776-109776
Closed Access | Times Cited: 5

The protective role of plant-derived proteins in Mediterranean diet against chronic non-communicable diseases
Nenad Ćetković, Giuseppe Guido Maria Scarlata, Anna Caterina Procopio, et al.
Minerva Biotechnology and Biomolecular Research (2024) Vol. 36, Iss. 1
Closed Access | Times Cited: 1

Does the Human Gut Virome Contribute to Host Health or Disease?
Grazia Pavia, Nadia Marascio, Giovanni Matera, et al.
Viruses (2023) Vol. 15, Iss. 11, pp. 2271-2271
Open Access | Times Cited: 4

HO-1-induced autophagy establishes a HO-1-p62-Nrf2 positive feedback loop to reduce gut permeability in cholestatic liver disease
Pingping Ren, Wei Lei, Changcheng Zhao, et al.
Scandinavian Journal of Gastroenterology (2024) Vol. 59, Iss. 8, pp. 906-917
Closed Access

Advances in the study of oral microbiota and metabolism associated fatty liver disease: a systematic review
Mingming Huang, Xinbi Zhang, Rui Zhou, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access

Decoding MASLD’s Pathophysiology
Ludovico Abenavoli, Giuseppe Guido Maria Scarlata
(2024), pp. 15-24
Closed Access

Impact of dietary fiber fraction of chia seed supplementation on hepatic steatosis and other metabolic disturbances in a high-fat diet model
Camila Cisternas, Camila Farías, Rodrigo Valenzuela, et al.
Journal of Functional Foods (2024) Vol. 119, pp. 106329-106329
Open Access

The effects of stress on gut virome: Implications on infectious disease and systemic disorders
F Talarico, Bruno Tilocca, Rocco Spagnuolo, et al.
MicrobiologyOpen (2024) Vol. 13, Iss. 5
Open Access

Metabolic-associated fatty liver disease and pregnancy complications: new challenges and clinical perspectives
Yang Zhang, Yifan Bu, Rui Zhao, et al.
Therapeutic Advances in Endocrinology and Metabolism (2024) Vol. 15
Open Access

Page 1 - Next Page

Scroll to top